iOncologi's Patented RNA Innovations Promise Enhanced Cancer Immunotherapy Outcomes iOncologi has secured a key U.S. patent for RNA-based cancer therapies, connecting COVID-19 mRNA vaccines to improved immunotherapy responses.

iOncologi's Patented RNA Innovations Promise Enhanced Cancer Immunotherapy Outcomes #United_States #Gainesville #Cancer_Immunotherapy #RNA_Therapies #iOncologi

Collaboration Between SandboxAQ and iOncologi Aims to Innovate Glioblastoma Treatment Through AI Technology The partnership of SandboxAQ and iOncologi seeks to revolutionize glioblastoma treatment by leveraging AI-driven drug discovery, potentially leading to novel therapies.

Collaboration Between SandboxAQ and iOncologi Aims to Innovate Glioblastoma Treatment Through AI Technology #USA #Palo_Alto #Glioblastoma #SandboxAQ #iOncologi

iOncologi, Inc. Welcomes New Board Members to Enhance Immunotherapy Strategies iOncologi, Inc. has appointed Dr. Mona Flores and Mr. Paolo Fundarò to its Board of Directors, aimed at advancing innovative immunotherapy for cancer treatment.

iOncologi, Inc. Welcomes New Board Members to Enhance Immunotherapy Strategies #USA #Gainesville #iOncologi #Dr._Mona_Flores #Paolo_Fundarò

iOncologi, Inc. Expands Immunotherapy Capabilities with TargImmune Acquisition iOncologi, Inc. announces the acquisition of TargImmune Therapeutics to enhance its immunotherapy pipeline aimed at solid tumors. This strategic move reinforces its mission in cancer treatment.

iOncologi, Inc. Expands Immunotherapy Capabilities with TargImmune Acquisition #United_States #Gainesville #Immunotherapy #iOncologi #TargImmune